XM does not provide services to residents of the United States of America.
A
A

AuroraCannabis

News

CGI, Empire Company, Kinaxis

CANADA RESEARCH ROUNDUP-CGI, Empire Company, Kinaxis June 21 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including CGI, Empire Company and Kinaxis, on Friday. HIGHLIGHTS * Alimentation Couche-Tard ATD.TO : Canaccord Genuity raises PT to C$87 from C$84 * Canadian Natural Resources Ltd CNQ.TO : Wells Fargo cuts PT to C$52 from C$56 * CGI Inc GIBa.TO : CIBC cuts to neutral from outperformer * Empire Company Ltd EMPa.TO : Desjardins raises t
A

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hit record highs on Thursday, boosted by strong gains in Nvidia, while investors assessed recent economic data and commentary from Federal Reserve officials to gauge the timing of interest-rate cuts this year.
G
K
M
N
U
U
D
A
D

Aurora Cannabis falls as Q4 revenue misses estimates

BUZZ-Aurora Cannabis falls as Q4 revenue misses estimates ** Shares of Canada's Aurora Cannabis ACB.TO fall 5.95% to C$7.27 ** Posts fiscal Q4 net revenue of C$67.40 mln ($49.19 million), below est. of C$70.50 mln - LSEG data ** Consumer cannabis revenue declines to C$10.20 mln vs. C$14.50 mln a year earlier ** Adj. core profit falls to C$1.90 mln,
A

Stocks up as Swiss cut again, BoE eyed; yuan slides

MORNING BID AMERICAS-Stocks up as Swiss cut again, BoE eyed; yuan slides A look at the day ahead in U.S. and global markets from Mike Dolan Wall Street returns from its midweek break to find record high stocks still chomping at the bit, with overseas monetary easing in focus as the Swiss cut interest rates for the second time this year and the Bank of England decision now awaited.
C
G
K
M
N
T
U
U
J
U
U
F
A
D

Aurora Cannabis Announce Arrival Of Aurora Branded Medical Cannabis Products To New Zealand Market

BRIEF-Aurora Cannabis Announce Arrival Of Aurora Branded Medical Cannabis Products To New Zealand Market May 8 (Reuters) - Aurora Cannabis Inc ACB.TO : AURORA CANNABIS INC: ANNOUNCE ARRIVAL OF AURORA BRANDED MEDICAL CANNABIS PRODUCTS TO NEW ZEALAND MARKET Source text for Eikon: ID:nPn4CwVqna Further company coverage: ACB.TO
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.